BluePrint
80-gene RNA-expression assay for molecular subtype classification in breast cancer.
- Developer
- Agendia
- Intended use
- Other
- Cancer scope
- Breast cancer
- Specimen
- Breast tumor tissue
- Molecular modality
- RNA expression
- Current version
- Current BluePrint configuration (2026-09)
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.